相关实验视频

Updated: Jun 13, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

在优化心脏再同步治疗期间,优先考虑心室再同步与左心室填充的急性血液动力学效应的比较

Yixiu Liang¹, Ahran D Arnold², Nadine Ali²

¹Department of Cardiology, Zhongshan Hospital of Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Centre for Interventional Medicine, Shanghai, China; National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, United Kingdom.

|September 12, 2024

概括

在心脏再同步治疗 (CRT) 期间优化左心室 (LV) 填充,比准最大心室再同步更好地改善急性血液动力性能. 建议在CRT编程中优先考虑LV填充.

科学领域:

心脏病学心脏病学
电子生理学电子生理学
心脏再同步治疗心脏再同步治疗

背景情况:

心脏再同步治疗 (CRT) 通常针对最大心室再同步,旨在获得最短的QRS持续时间 (QRSd).
对CRT的最佳编程策略,平衡电气和血液动力学参数,仍然是积极研究的领域.

研究的目的:

为了比较优化心室再同步与优化左心室 (LV) 填充在CRT期间的急性血液动力学效应.
为了评估是否针对最短的QRSd或最有效的LV填充产生优越的血液动力学结果.

主要方法:

在30名具有标准CRT征兆的患者中,对双心脏节奏 (BVP) 和左束枝节奏 (LBBP) 的患者内部比较.
通过测量静脉血压 (SBP) 在不同心房延迟 (AVD) 时评估急性血液动力学反应.
使用QRS面积 (QRSa) 进行电气评估,并在验证副研究中使用LV压力上升的最大速度 (dP/dtmax) 进行血液动力学评估.

主要成果:

对于最大腹腔再同步的心房延迟 (AVD) 与显著更短的QRSd相关,但与优化LV填充的AVD相比,SBP的改善较小.
在子研究中观察到类似的发现,其中优化QRSd或QRSa导致dP/dtmax的改善较小.
当被编程为最大心室重同步时,BVP和LBBP都显示出低于最佳的急性血液动力性能.

结论:

编程CRT以实现最大心室再同步,导致低于最佳的急性血液动力性能.
在CRT编程期间优先考虑左心室 (LV) 填充,这些发现支持改善血液动力学结果.
这些结果表明CRT优化策略的转变,强调LV填充,专注于QRSd减少.

关键词:

房延迟是因为房延迟双管节奏是双管节奏的节奏.心脏再同步治疗心脏再同步治疗血液动力学血液动力学左束枝分支步行步行步行步行.室腔同步室腔同步室腔同步

更多相关视频

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...